Supports Value of Insights Provided by Brain Recordings from the NeuroPace RNS® System for Drug-Resistant Epilepsy MOUNTAIN VIEW, Calif. – February 12, 2019 – NeuroPace, Inc., a…
More than One-Third of Drug-Resistant Epilepsy Patients Achieved ≥90% Seizure Reduction with the RNS System. NEW ORLEANS--(BUSINESS WIRE)--American Epilepsy Society Annual Meeting, Booth 519 —…
Next Gen RNS System provides unprecedented brain data with long-lasting, 8-year battery life. MOUNTAIN VIEW, Calif -- June 1, 2018 – NeuroPace, Inc., a Silicon…
WASHINGTON--(EON: Enhanced Online News)--American Epilepsy Society Annual Meeting, Booth 1101--NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop…
MOUNTAIN VIEW, Calif. – October 24, 2017 – NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive…
MOUNTAIN VIEW, California – February 20, 2017 – NeuroPace, Inc. announced today that the 1000th patient has been treated with its award-winning RNS® System, approved…